Carina Biotech An Australian clinical stage immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. Carina are working towards producing broad-spectrum CAR-T therapies that can be used to treat multiple solid cancers yet are patient-specific and result in little, if any, off-cancer damage. Using its proprietary platforms, Carina is also developing technologies to improve access to, and infiltration of, solid cancers, and to enhance CAR-T cell manufacturing. We are working to… 1. Expand the clinical indications for T cell therapies 2. Improve the commercial viability of T cell therapies by developing supporting technologies that make T cell therapies more effective or economically viable Headquartered in Adelaide, South Australia, Carina has strong T cell R&D capability across a network of research providers and collaborators including leading scientists at the UniSA, the Women's & Children's Hospital in Adelaide, the University of Adelaide, the Royal Prince Alfred Hospital in NSW and the Seattle Children's Hospital in the United States.
View Top Employees from Carina BiotechWebsite | http://carinabiotech.com |
Employees | 16 (8 on RocketReach) |
Founded | 2016 |
Address | Level 5, Catherine Helen Spence Building, UniSA City West Campus, Adelaide, South Australia 5000, AU |
Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
Industry | Biotechnology Research, CAR-T cells, Immunotherapy, T cell biology, Cancer Biology, Biomaterials, Research & Development, Biotechnology, Science |
Looking for a particular Carina Biotech employee's phone or email?
Stephen Livesey is the Board Member of Carina Biotech.
8 people are employed at Carina Biotech.
Carina Biotech is based in Adelaide, South Australia.